Myriad Genetics, Inc. (MYGN) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Myriad Genetics, Inc. (MYGN)

An SI Board Since August 1996

Posts	SubjectMarks	Bans	Symbol
2355	65	0	MYGN

Emcee: s myers	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1130	Lee, Rick does not generally do options but for others, given the trial data is	Robohogs	-	4/19/2005
1129	If prescient early investors like you guys have ulcers, what disease indications	Lee39	-	4/19/2005
1128	Yes, the reply was from Bill Hockett. You must know them all. :-)	LJM	-	4/19/2005
1127	Thanks Rick. Jon	Robohogs	-	4/19/2005
1126	AACR yesterday.... news from a friend..... 6827 has finished first cohort,	scaram(o)uche	-	4/19/2005
1125	Thanks, Lee. Between Nigel and me, this shelf has yielded two ulcers. A litt	scaram(o)uche	-	4/19/2005
1124	Meldrum certainly said the strategy is "go it alone" in 3 areas, AIDS,	Lee39	-	4/19/2005
1123	That response from Hockett (presuming) really bugs me. They have clearly said t	scaram(o)uche	-	4/19/2005
1122	for the first time (the posturing is b.s., others here know that from listening	scaram(o)uche	-	4/19/2005
1121	That, to my naive ear, sounds similar to what Biomaven was saying.	scaram(o)uche	-	4/18/2005
1120	They may also be late reporting of VWAP trades which are when brokerages guarant	Robohogs	-	4/18/2005
1119	I think PM is worth at least $15 pps myself. I agree with Rick that they should	Robohogs	-	4/18/2005
1118	>> Meldrum's anti-partnering stance would look more logical if flurbie	scaram(o)uche	-	4/18/2005
1117	>> what's insane about the short, at least for a few weeks? <<	scaram(o)uche	-	4/18/2005
1116	I don't know. They come after hours, are largest on days when there's b	scaram(o)uche	-	4/18/2005
1115	huh? no, Tom, not at all. I'm just trying to figure out why I've been	scaram(o)uche	-	4/18/2005
1114	MYGN has done very well in PM last 5 Q, cann't think anyone else with this	Lee39	-	4/18/2005
1113	What is an "accounting trade?" Jon	Robohogs	-	4/18/2005
1112	Rick, At least he hasn't done a convert and then given the hedge funds shar	Robohogs	-	4/18/2005
1111	I realize that Rick has essentially told me to shut up and stop posting (the wor	tom pope	-	4/18/2005
1110	AACR all preclinical. See nothing at ASCO . . . has the company given an	tuck	-	4/18/2005
1109	Study of Breast Cancer Patients Showed Regimen Including EMEND-R- -aprepitant- P	scaram(o)uche	-	4/18/2005
1108	>> The concept of his being able to handle that, at the same time that the	scaram(o)uche	-	4/18/2005
1107	>> Look at the record, Myriad has done many deals with large pharma. <&	scaram(o)uche	-	4/18/2005
1106	>> Mr. Meldrum has however, said that we intend to develop cancer drugs an	scaram(o)uche	-	4/18/2005

Go to reply# or date (mm/dd/yy):